SMS Reminder
BehavioralCaregivers will receive two text message reminders for their child's measles immunization scheduled for 9 months of age
NCT Number: NCT02904642
The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Primary Objective The primary objective is to determine if text message reminders, with or without unconditionally provided incentives, can increase the proportion of children who receive measles vaccination by 15% at age ten months as compared to control arm children.
Secondary Objectives
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Caregivers will receive two text message reminders for their child's measles immunization scheduled for 9 months of age
A mobile-money incentive in the amount of 150 Kenyan Shillings will be transferred to the enrolled caregiver's mobile phone when the child reaches nine months of age
Time frame: 10 months
Proportion of children receiving measles vaccination by 10 months of age by study arm
Time frame: 12 months
As a secondary analysis of the primary outcome, time-to-measles immunization curves will be constructed using the Kaplan-Meier method and study arms will be compared using the Cox model. The 25th, 50th, and 75th percentiles for time to immunization and the number of days delayed, in relation to the measles due date, will also be reported for each vaccine and by study arm.
Time frame: 10 months
A priori we will conduct sub group analyses of the primary outcome for mobile phone ownership, birth order of the enrolled caregiver's child, and time to clinic. Additional variables for subgroup analyses will come from a risk factor analysis of not receiving measles vaccination in the control arm
Time frame: 12 months
Proportion of children who receive measles vaccination by twelve months of age by study arm
Time frame: 24 months
This outcome is dependent on receiving more funding
Johns Hopkins Bloomberg School of Public Health
Other
Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial
Acronym: M-SIMI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02325310
Infections, Measles
Paris, France
View Trial DetailsNCT06331702
Arbovirus Infections, Brain Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT03071575
Abnormalities, Multiple, Congenital Abnormalities
Chāndpur, Bangladesh
View Trial DetailsNCT05630846
Chickenpox, DNA Virus Infections
Birmingham, Alabama, United States
View Trial Details